KJIM :: Korean Journal of Internal Medicine

Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

Andrea Boccatonda, Lorenza Del Cane, Lara Marola, Damiano D’Ardes, Gianfranco Lessiani, Nicoletta di Gregorio, Claudio Ferri, Francesco Cipollone, Carla Serra, Francesca Santilli, Fabio Piscaglia

ASSOCIATION BETWEEN ANXIETY AND DEPRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

Eloyse Cristina BOTACIN, Sebastião Mauro Bezerra DUARTE, José Tadeu STEFANO, Mary Ellen Dias BARBOSA, Mario Guimarães PESSOA, Cláudia P OLIVEIRA

Arquivos de Gastroenterologia.2024;[Epub] CrossRef

Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease

Protein & Peptide Letters.2024; 31(4): 290. CrossRef

Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis

Katherine J.P. Schwenger, Alexander Kiu, Maryam AlAli, Amnah Alhanaee, Sandra E. Fischer, Johane P. Allard

Nonalcoholic Fatty Liver Disease Among Obese Patients in Oman

Hamdi Al Mutori, Mazin Al Rudaini, Ahmed F. Omar, Sanam Anwar, Yasser Selim, Bahaa Yaseen

Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis

Maya Balakrishnan, Parth Patel, Sydney Dunn-Valadez, Cecilia Dao, Vinshi Khan, Hiba Ali, Laith El-Serag, Ruben Hernaez, Amy Sisson, Aaron P. Thrift, Yan Liu, Hashem B. El-Serag, Fasiha Kanwal

Clinical Gastroenterology and Hepatology.2021; 19(1): 61. CrossRef

Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease

Evangelia Makri, Antonis Goulas, Stergios A. Polyzos

Archives of Medical Research.2021; 52(1): 25. CrossRef

Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients

Adrian T. Billeter, Sarah Wloka, Rouven Behnisch, Thomas Albrecht, Stephanie Roessler, Benjamin Goeppert, Sebastian Mueller, Felix Nickel, Beat Müller

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Naga Chalasani, Zobair Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A. Harrison, Elizabeth M. Brunt, Arun J. Sanyal

NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances

Mazen Noureddin, Aarshi Vipani, Catherine Bresee, Tsuyoshi Todo, Irene K. Kim, Naim Alkhouri, Veronica Wendy Setiawan, Tram Tran, Walid S. Ayoub, Shelly C. Lu, Andrew S. Klein, Vinay Sundaram, Nicholas N. Nissen

American Journal of Gastroenterology.2018; 113(11): 1649. CrossRef

Thrombocytopenia as a marker of liver steatosis in a low-endemic area for schistosomiasis mansoni

Alba Otoni, Carlos Mauricio de Figueiredo Antunes, Fernanda Ferreira Tavares, Débora Heloísa Quadros Araújo, Thiago de Almeida Pereira, Leonardo Campos de Queiroz, Frederico Figueiredo Amâncio, José Roberto Lambertucci

Revista da Associação Médica Brasileira.2017; 63(6): 532. CrossRef

Predictive Factors of Steatosis and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Undergoing Bariatric Surgery

Behrooz Kalidari, Mohsen Mahmoudieh, Hamid Melali, Mehdi Nazari Moghadam, Mohsen Kolahdouzan

Association Between Platelet Count as a Noninvasive Marker and Ultrasonographic Grading in Patients With Nonalcoholic Fatty Liver Disease

Afagh Garjani, Abdolrasoul Safaeiyan, Manouchehr Khoshbaten

Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects

Ming Hong, Sha Li, Hor Tan, Ning Wang, Sai-Wah Tsao, Yibin Feng

International Journal of Molecular Sciences.2015; 16(12): 28705. CrossRef

Hepatic angiogenesis and fibrosis are common features in morbidly obese patients

Monika Ciupińska-Kajor, Marek Hartleb, Maciej Kajor, Michał Kukla, Mariusz Wyleżoł, Dariusz Lange, Łukasz Liszka

Hepatology International.2013; 7(1): 233. CrossRef

Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome

Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim

The Korean Journal of Internal Medicine.2012; 27(1): 47. CrossRef

R Christopher Harmon, Dina G Tiniakos, Curtis K Argo

Expert Review of Gastroenterology & Hepatology.2011; 5(2): 189. CrossRef

Platelet count for predicting fibrosis in nonalcoholic fatty liver disease

Masato Yoneda, Hideki Fujii, Yoshio Sumida, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Kento Imajo, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshik

Journal of Gastroenterology.2011; 46(11): 1300. CrossRef

Nonalcoholic fatty liver disease across ethno‐racial groups: Do Asian‐American adults represent a new at‐risk population?

James H. Tabibian, Mariana Lazo, Francisco A. Durazo, Hsin‐Chieh Yeh, Myron J. Tong, Jeanne M. Clark

Journal of Gastroenterology and Hepatology.2011; 26(3): 501. CrossRef

Sophocarpine alleviates non‐alcoholic steatohepatitis in rats

Chun‐Yan Song, Xin Zeng, Si‐Wen Chen, Ping‐Fang Hu, Zhi‐Wu Zheng, Bei‐Fang Ning, Jian Shi, Wei‐Fen Xie, Yue‐Xiang Chen

Journal of Gastroenterology and Hepatology.2011; 26(4): 765. CrossRef

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

Curtis K. Argo, Patrick G. Northup, Abdullah M.S. Al-Osaimi, Stephen H. Caldwell

Epidemiology and Natural History of Non-Alcoholic Steatohepatitis

Clinics in Liver Disease.2009; 13(4): 511. CrossRef

Current status of liver disease in Korea: Nonalcoholic fatty liver disease

The Korean Journal of Hepatology.2009; 15(Suppl 6): S34. CrossRef

Predictors of pathological severity in non‐alcoholic fatty liver disease: Is East meeting West in the middle?

Journal of Gastroenterology and Hepatology.2007; 22(4): 461. CrossRef

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

Thierry Poynard, Vlad Ratziu, Frederic Charlotte, Djamila Messous, Mona Munteanu, Françoise Imbert-Bismut, Julien Massard, Luninita Bonyhay, Mohamed Tahiri, Dominique Thabut, Jean François Cadranel, Brigitte Le Bail, Victor de Ledinghen

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C

Chun-Jen Liu, Pei-Jer Chen, Yung-Ming Jeng, Wen-Ling Huang, Wei-Shiung Yang, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen

Influence of Metabolic Syndrome, Viral Genotype and Antiviral Therapy on Superimposed Fatty Liver Disease in Chronic Hepatitis C

Chun-Jen Liu, Yung-Ming Jeng, Pei-Jer Chen, Ming-Yang Lai, Hung-Chih Yang, Wen-Ling Huang, Jia-Horng Kao, Ding-Shinn Chen